Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia. [electronic resource]
Producer: 20090528Description: 1147-8; author reply 1149-50 p. digitalISSN:- 1873-5835
- Antineoplastic Agents -- administration & dosage
- Benzamides
- Cytogenetic Analysis
- Drug Monitoring
- Female
- Fusion Proteins, bcr-abl -- analysis
- Humans
- Imatinib Mesylate
- In Situ Hybridization, Fluorescence
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- blood
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Chronic-Phase
- Male
- Middle Aged
- Piperazines -- administration & dosage
- Polymerase Chain Reaction
- Pyrimidines -- administration & dosage
- Risk Assessment
No physical items for this record
Publication Type: Comment; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.